Skip to main content

Carruthers Wendy's Form 4 filing

Boston Scientific Corp (BSX) · filed Mar 4, 2024

Accession no.
0001225208-24-003504
Filed
Mar 4, 2024
Trade date
Mar 1, 2024
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $463.3K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Carruthers WendyCIK 0001563565Officer (EVP, Human Resources)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 1, 2024Common StockMOption exerciseAcquired+3,066$17.26+$52,919.1659,574Direct
Mar 1, 2024Common StockMOption exerciseAcquired+1,197$24.55+$29,386.3560,771Direct
Mar 1, 2024Common StockSSaleDisposed−6,983$66.35−$463,322.0553,788Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 1, 2024Common StockMOption exerciseDisposed−3,066$0.00$027,594Direct
Mar 1, 2024Common StockMOption exerciseDisposed−1,197$0.00$023,956Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)